

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.74391911 |
| 2 | modulation by symbiont of host immune response (GO:0052553) | 5.18829037 |
| 3 | positive regulation by symbiont of host defense response (GO:0052509) | 5.18829037 |
| 4 | modulation by symbiont of host defense response (GO:0052031) | 5.18829037 |
| 5 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.18829037 |
| 6 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.18829037 |
| 7 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.18829037 |
| 8 | response to peptidoglycan (GO:0032494) | 5.00733394 |
| 9 | cellular extravasation (GO:0045123) | 4.86614937 |
| 10 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.85073065 |
| 11 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.54362227 |
| 12 | detection of molecule of bacterial origin (GO:0032490) | 4.45721747 |
| 13 | response to muramyl dipeptide (GO:0032495) | 4.40330472 |
| 14 | B cell receptor signaling pathway (GO:0050853) | 4.30386121 |
| 15 | regulation of gamma-delta T cell activation (GO:0046643) | 4.13052634 |
| 16 | germinal center formation (GO:0002467) | 4.09067811 |
| 17 | neutrophil activation involved in immune response (GO:0002283) | 4.06282959 |
| 18 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.05209822 |
| 19 | macrophage activation involved in immune response (GO:0002281) | 3.99721997 |
| 20 | response to host immune response (GO:0052572) | 3.94537699 |
| 21 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.94537699 |
| 22 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.90692792 |
| 23 | negative regulation of interleukin-12 production (GO:0032695) | 3.84943020 |
| 24 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.83532914 |
| 25 | negative regulation of cell killing (GO:0031342) | 3.83532914 |
| 26 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.79864347 |
| 27 | response to host (GO:0075136) | 3.79864347 |
| 28 | response to host defenses (GO:0052200) | 3.79864347 |
| 29 | detection of other organism (GO:0098543) | 3.77871236 |
| 30 | response to interleukin-15 (GO:0070672) | 3.62761800 |
| 31 | detection of external biotic stimulus (GO:0098581) | 3.58523758 |
| 32 | positive regulation of B cell differentiation (GO:0045579) | 3.56345498 |
| 33 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.51166978 |
| 34 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.48708181 |
| 35 | neutrophil activation (GO:0042119) | 3.46837093 |
| 36 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.40249698 |
| 37 | detection of bacterium (GO:0016045) | 3.32028476 |
| 38 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.30197478 |
| 39 | negative thymic T cell selection (GO:0045060) | 3.23287110 |
| 40 | B cell homeostasis (GO:0001782) | 3.22469067 |
| 41 | regulation of B cell differentiation (GO:0045577) | 3.21467673 |
| 42 | granulocyte activation (GO:0036230) | 3.19836298 |
| 43 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.19544114 |
| 44 | detection of biotic stimulus (GO:0009595) | 3.19294281 |
| 45 | nuclear pore complex assembly (GO:0051292) | 3.18787989 |
| 46 | macrophage activation (GO:0042116) | 3.18551869 |
| 47 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 3.18310634 |
| 48 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.16451517 |
| 49 | negative regulation of T cell mediated immunity (GO:0002710) | 3.16226854 |
| 50 | myeloid cell activation involved in immune response (GO:0002275) | 3.15579237 |
| 51 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.08598086 |
| 52 | histone H3-K4 trimethylation (GO:0080182) | 3.07099830 |
| 53 | cellular response to interleukin-15 (GO:0071350) | 3.05334813 |
| 54 | regulation of mast cell degranulation (GO:0043304) | 3.04195326 |
| 55 | neutrophil mediated immunity (GO:0002446) | 3.03481601 |
| 56 | negative T cell selection (GO:0043383) | 3.03358402 |
| 57 | positive regulation of interferon-alpha production (GO:0032727) | 3.03039253 |
| 58 | T-helper 1 type immune response (GO:0042088) | 3.02776014 |
| 59 | immunoglobulin mediated immune response (GO:0016064) | 3.02305128 |
| 60 | embryonic process involved in female pregnancy (GO:0060136) | 3.00890090 |
| 61 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.99859243 |
| 62 | positive regulation of granulocyte differentiation (GO:0030854) | 2.97513471 |
| 63 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.94590576 |
| 64 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.93068816 |
| 65 | microglial cell activation (GO:0001774) | 2.90518978 |
| 66 | regulation of histone H3-K27 methylation (GO:0061085) | 2.90261699 |
| 67 | leukocyte aggregation (GO:0070486) | 2.87808096 |
| 68 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.87341055 |
| 69 | T cell migration (GO:0072678) | 2.87182405 |
| 70 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.86136052 |
| 71 | positive thymic T cell selection (GO:0045059) | 2.84556051 |
| 72 | response to protozoan (GO:0001562) | 2.81412065 |
| 73 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.81194968 |
| 74 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.81173115 |
| 75 | defense response to protozoan (GO:0042832) | 2.79002860 |
| 76 | regulation of interferon-alpha production (GO:0032647) | 2.76573251 |
| 77 | tolerance induction (GO:0002507) | 2.75883894 |
| 78 | cellular response to ethanol (GO:0071361) | 2.74471412 |
| 79 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.74393063 |
| 80 | NIK/NF-kappaB signaling (GO:0038061) | 2.72984334 |
| 81 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.72842211 |
| 82 | leukocyte degranulation (GO:0043299) | 2.72706128 |
| 83 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.71445094 |
| 84 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.70307223 |
| 85 | regulation of toll-like receptor signaling pathway (GO:0034121) | 2.69627103 |
| 86 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.68656541 |
| 87 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.68656541 |
| 88 | regulation of mast cell activation (GO:0033003) | 2.68470560 |
| 89 | regulation of leukocyte degranulation (GO:0043300) | 2.67457487 |
| 90 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.67321606 |
| 91 | histone H3-K36 demethylation (GO:0070544) | 2.66498848 |
| 92 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.65653006 |
| 93 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.65579684 |
| 94 | megakaryocyte development (GO:0035855) | 2.64542858 |
| 95 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.64315413 |
| 96 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.62438759 |
| 97 | B cell mediated immunity (GO:0019724) | 2.61324814 |
| 98 | mannose metabolic process (GO:0006013) | 2.61324704 |
| 99 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.60490563 |
| 100 | respiratory burst (GO:0045730) | 2.60186570 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 4.60339544 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.32130178 |
| 3 | MYC_22102868_ChIP-Seq_BL_Human | 3.93272034 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.73761822 |
| 5 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.67389638 |
| 6 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.55122786 |
| 7 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.20846899 |
| 8 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.09041209 |
| 9 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.02852027 |
| 10 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.94973774 |
| 11 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.88447944 |
| 12 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.86477705 |
| 13 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.74324179 |
| 14 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.63160943 |
| 15 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.59890392 |
| 16 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.59865143 |
| 17 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.58618105 |
| 18 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.57628211 |
| 19 | MYB_26560356_Chip-Seq_TH2_Human | 2.57273082 |
| 20 | MAF_26560356_Chip-Seq_TH1_Human | 2.54028010 |
| 21 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.47580569 |
| 22 | MYB_26560356_Chip-Seq_TH1_Human | 2.37207159 |
| 23 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.31938082 |
| 24 | SPI1_23127762_ChIP-Seq_K562_Human | 2.31453039 |
| 25 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.28567228 |
| 26 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.27988453 |
| 27 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.27612296 |
| 28 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.26860053 |
| 29 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.24842538 |
| 30 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.20705727 |
| 31 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.18456640 |
| 32 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.16813908 |
| 33 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.12395393 |
| 34 | UTX_26944678_Chip-Seq_JUKART_Human | 2.11934767 |
| 35 | GATA1_22025678_ChIP-Seq_K562_Human | 2.01204553 |
| 36 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.99718904 |
| 37 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.98607871 |
| 38 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.94516555 |
| 39 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.91291717 |
| 40 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.88365527 |
| 41 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.84001879 |
| 42 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.77693265 |
| 43 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.76095186 |
| 44 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.74994623 |
| 45 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.74235394 |
| 46 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.71650076 |
| 47 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.69301016 |
| 48 | MAF_26560356_Chip-Seq_TH2_Human | 1.68229577 |
| 49 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.63007542 |
| 50 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.61114917 |
| 51 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.58367388 |
| 52 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.55432998 |
| 53 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.54281762 |
| 54 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.53174987 |
| 55 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.49353959 |
| 56 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.48956700 |
| 57 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.47843318 |
| 58 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.47764290 |
| 59 | GATA1_19941826_ChIP-Seq_K562_Human | 1.46949718 |
| 60 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.45039149 |
| 61 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.42209747 |
| 62 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.40344071 |
| 63 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.30772635 |
| 64 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.28314786 |
| 65 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.28304958 |
| 66 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.28136005 |
| 67 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.27304905 |
| 68 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.23242510 |
| 69 | GATA2_19941826_ChIP-Seq_K562_Human | 1.21373347 |
| 70 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.19084344 |
| 71 | GATA3_26560356_Chip-Seq_TH2_Human | 1.16136279 |
| 72 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.11525078 |
| 73 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10417653 |
| 74 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.10332585 |
| 75 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.07292123 |
| 76 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03527899 |
| 77 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.01499210 |
| 78 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00200140 |
| 79 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.96310421 |
| 80 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.95723260 |
| 81 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.94456086 |
| 82 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.94338423 |
| 83 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.93608957 |
| 84 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.92942379 |
| 85 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.91993733 |
| 86 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.91196354 |
| 87 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.89167808 |
| 88 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.88794478 |
| 89 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.88659809 |
| 90 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.88656849 |
| 91 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.88012960 |
| 92 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.86817972 |
| 93 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.86362998 |
| 94 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.85523392 |
| 95 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.84768267 |
| 96 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.83707661 |
| 97 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.82801446 |
| 98 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.81644430 |
| 99 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 0.81063871 |
| 100 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.77201044 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 3.97094105 |
| 2 | MP0003436_decreased_susceptibility_to | 3.65739298 |
| 3 | MP0001835_abnormal_antigen_presentation | 3.46693708 |
| 4 | MP0003724_increased_susceptibility_to | 3.21969007 |
| 5 | MP0002396_abnormal_hematopoietic_system | 3.17456404 |
| 6 | MP0001800_abnormal_humoral_immune | 2.84478014 |
| 7 | MP0000685_abnormal_immune_system | 2.82529152 |
| 8 | MP0002419_abnormal_innate_immunity | 2.66858478 |
| 9 | MP0005000_abnormal_immune_tolerance | 2.56447549 |
| 10 | MP0005387_immune_system_phenotype | 2.47932299 |
| 11 | MP0001790_abnormal_immune_system | 2.47932299 |
| 12 | MP0005451_abnormal_body_composition | 2.43986992 |
| 13 | MP0002452_abnormal_antigen_presenting | 2.40769441 |
| 14 | MP0002723_abnormal_immune_serum | 2.36963470 |
| 15 | MP0002420_abnormal_adaptive_immunity | 2.32723523 |
| 16 | MP0001819_abnormal_immune_cell | 2.29241961 |
| 17 | MP0005025_abnormal_response_to | 2.26578365 |
| 18 | MP0005671_abnormal_response_to | 2.24709715 |
| 19 | MP0003763_abnormal_thymus_physiology | 2.22305175 |
| 20 | MP0002398_abnormal_bone_marrow | 2.15271027 |
| 21 | MP0008260_abnormal_autophagy | 2.11944214 |
| 22 | MP0003300_gastrointestinal_ulcer | 2.09807713 |
| 23 | MP0008057_abnormal_DNA_replication | 2.08132899 |
| 24 | MP0005464_abnormal_platelet_physiology | 2.04404971 |
| 25 | MP0003172_abnormal_lysosome_physiology | 1.96862098 |
| 26 | MP0002166_altered_tumor_susceptibility | 1.91595602 |
| 27 | MP0000716_abnormal_immune_system | 1.90425805 |
| 28 | MP0009278_abnormal_bone_marrow | 1.87688205 |
| 29 | MP0003656_abnormal_erythrocyte_physiolo | 1.86537371 |
| 30 | MP0004947_skin_inflammation | 1.84564937 |
| 31 | MP0004808_abnormal_hematopoietic_stem | 1.82302734 |
| 32 | MP0002405_respiratory_system_inflammati | 1.81400820 |
| 33 | MP0002722_abnormal_immune_system | 1.80535496 |
| 34 | MP0000689_abnormal_spleen_morphology | 1.77984347 |
| 35 | MP0005076_abnormal_cell_differentiation | 1.77719186 |
| 36 | MP0009785_altered_susceptibility_to | 1.75278558 |
| 37 | MP0005397_hematopoietic_system_phenotyp | 1.67757055 |
| 38 | MP0001545_abnormal_hematopoietic_system | 1.67757055 |
| 39 | MP0000703_abnormal_thymus_morphology | 1.66226039 |
| 40 | MP0002429_abnormal_blood_cell | 1.63096504 |
| 41 | MP0002148_abnormal_hypersensitivity_rea | 1.62725950 |
| 42 | MP0003828_pulmonary_edema | 1.54770675 |
| 43 | MP0002006_tumorigenesis | 1.53606613 |
| 44 | MP0002009_preneoplasia | 1.53075295 |
| 45 | MP0005310_abnormal_salivary_gland | 1.50500660 |
| 46 | MP0010155_abnormal_intestine_physiology | 1.50094415 |
| 47 | MP0010352_gastrointestinal_tract_polyps | 1.49301203 |
| 48 | MP0001853_heart_inflammation | 1.49033564 |
| 49 | MP0001533_abnormal_skeleton_physiology | 1.47066094 |
| 50 | MP0002132_abnormal_respiratory_system | 1.45112232 |
| 51 | MP0001845_abnormal_inflammatory_respons | 1.41593063 |
| 52 | MP0004381_abnormal_hair_follicle | 1.37657850 |
| 53 | MP0003221_abnormal_cardiomyocyte_apopto | 1.28078795 |
| 54 | MP0006082_CNS_inflammation | 1.22009222 |
| 55 | MP0009764_decreased_sensitivity_to | 1.21836656 |
| 56 | MP0009333_abnormal_splenocyte_physiolog | 1.20757319 |
| 57 | MP0000858_altered_metastatic_potential | 1.18414899 |
| 58 | MP0003091_abnormal_cell_migration | 1.16598847 |
| 59 | MP0003191_abnormal_cellular_cholesterol | 1.13866080 |
| 60 | MP0002998_abnormal_bone_remodeling | 1.12653679 |
| 61 | MP0008469_abnormal_protein_level | 1.08535419 |
| 62 | MP0001851_eye_inflammation | 1.08454672 |
| 63 | MP0003183_abnormal_peptide_metabolism | 1.08005374 |
| 64 | MP0003045_fibrosis | 1.05415243 |
| 65 | MP0002138_abnormal_hepatobiliary_system | 1.03264820 |
| 66 | MP0000465_gastrointestinal_hemorrhage | 1.01015843 |
| 67 | MP0001873_stomach_inflammation | 1.00457267 |
| 68 | MP0010094_abnormal_chromosome_stability | 0.97119416 |
| 69 | MP0003075_altered_response_to | 0.95290221 |
| 70 | MP0003866_abnormal_defecation | 0.94057951 |
| 71 | MP0004883_abnormal_blood_vessel | 0.93074100 |
| 72 | MP0008004_abnormal_stomach_pH | 0.91566175 |
| 73 | MP0010307_abnormal_tumor_latency | 0.90315577 |
| 74 | MP0009763_increased_sensitivity_to | 0.89855136 |
| 75 | MP0004510_myositis | 0.88548303 |
| 76 | MP0002019_abnormal_tumor_incidence | 0.88220036 |
| 77 | MP0005164_abnormal_response_to | 0.87358755 |
| 78 | MP0003111_abnormal_nucleus_morphology | 0.86112360 |
| 79 | MP0000569_abnormal_digit_pigmentation | 0.84711417 |
| 80 | MP0000609_abnormal_liver_physiology | 0.82404809 |
| 81 | MP0001915_intracranial_hemorrhage | 0.82170482 |
| 82 | MP0005058_abnormal_lysosome_morphology | 0.82013891 |
| 83 | MP0005621_abnormal_cell_physiology | 0.81499048 |
| 84 | MP0009765_abnormal_xenobiotic_induced | 0.79772890 |
| 85 | MP0000313_abnormal_cell_death | 0.78053453 |
| 86 | MP0008007_abnormal_cellular_replicative | 0.77510842 |
| 87 | MP0003566_abnormal_cell_adhesion | 0.77168554 |
| 88 | MP0002877_abnormal_melanocyte_morpholog | 0.77145115 |
| 89 | MP0008961_abnormal_basal_metabolism | 0.72774787 |
| 90 | MP0003077_abnormal_cell_cycle | 0.71955509 |
| 91 | MP0000015_abnormal_ear_pigmentation | 0.71893839 |
| 92 | MP0009115_abnormal_fat_cell | 0.70818844 |
| 93 | MP0003448_altered_tumor_morphology | 0.69236225 |
| 94 | MP0000350_abnormal_cell_proliferation | 0.62308291 |
| 95 | MP0002332_abnormal_exercise_endurance | 0.62110969 |
| 96 | MP0005409_darkened_coat_color | 0.61701031 |
| 97 | MP0003705_abnormal_hypodermis_morpholog | 0.61322082 |
| 98 | MP0002933_joint_inflammation | 0.60668261 |
| 99 | MP0000249_abnormal_blood_vessel | 0.60324393 |
| 100 | MP0000598_abnormal_liver_morphology | 0.60042165 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent bacterial skin infections (HP:0005406) | 4.47791691 |
| 2 | Recurrent abscess formation (HP:0002722) | 4.35125681 |
| 3 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.29094779 |
| 4 | Eczematoid dermatitis (HP:0000976) | 4.21987961 |
| 5 | Optic neuritis (HP:0100653) | 4.11121762 |
| 6 | Retrobulbar optic neuritis (HP:0100654) | 4.11121762 |
| 7 | Orchitis (HP:0100796) | 4.01030915 |
| 8 | Myositis (HP:0100614) | 3.92680075 |
| 9 | Recurrent viral infections (HP:0004429) | 3.82166903 |
| 10 | Recurrent cutaneous fungal infections (HP:0011370) | 3.77083490 |
| 11 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.77083490 |
| 12 | Recurrent fungal infections (HP:0002841) | 3.77005315 |
| 13 | Panhypogammaglobulinemia (HP:0003139) | 3.72162265 |
| 14 | Colitis (HP:0002583) | 3.60810256 |
| 15 | Meningitis (HP:0001287) | 3.60742202 |
| 16 | Abnormality of macrophages (HP:0004311) | 3.48282525 |
| 17 | Viral hepatitis (HP:0006562) | 3.44401574 |
| 18 | Recurrent skin infections (HP:0001581) | 3.35116737 |
| 19 | Encephalitis (HP:0002383) | 3.24563174 |
| 20 | Mediastinal lymphadenopathy (HP:0100721) | 3.22458854 |
| 21 | Gastrointestinal infarctions (HP:0005244) | 3.19923052 |
| 22 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.16241888 |
| 23 | Vasculitis (HP:0002633) | 3.15856173 |
| 24 | Abnormality of the fingertips (HP:0001211) | 3.15150617 |
| 25 | Agammaglobulinemia (HP:0004432) | 3.13580996 |
| 26 | Keratoconjunctivitis sicca (HP:0001097) | 3.12712909 |
| 27 | Inflammation of the large intestine (HP:0002037) | 3.10244435 |
| 28 | Spontaneous hematomas (HP:0007420) | 3.00891418 |
| 29 | Cellulitis (HP:0100658) | 2.99042521 |
| 30 | Gastrointestinal inflammation (HP:0004386) | 2.96953887 |
| 31 | Obstructive lung disease (HP:0006536) | 2.88484660 |
| 32 | Chronic obstructive pulmonary disease (HP:0006510) | 2.88484660 |
| 33 | Gastrointestinal stroma tumor (HP:0100723) | 2.86443607 |
| 34 | Prolonged bleeding time (HP:0003010) | 2.81712700 |
| 35 | Keratoconjunctivitis (HP:0001096) | 2.74662816 |
| 36 | Arterial thrombosis (HP:0004420) | 2.73647903 |
| 37 | T lymphocytopenia (HP:0005403) | 2.71466691 |
| 38 | Increased IgE level (HP:0003212) | 2.65993123 |
| 39 | Abnormality of T cell physiology (HP:0011840) | 2.62698745 |
| 40 | Abnormality of T cell number (HP:0011839) | 2.62669731 |
| 41 | Abnormality of the peritoneum (HP:0002585) | 2.59651017 |
| 42 | Autoimmune hemolytic anemia (HP:0001890) | 2.58501033 |
| 43 | Abnormality of T cells (HP:0002843) | 2.54818722 |
| 44 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.52695401 |
| 45 | Epistaxis (HP:0000421) | 2.52300553 |
| 46 | Subacute progressive viral hepatitis (HP:0006572) | 2.41565344 |
| 47 | Gingival bleeding (HP:0000225) | 2.41030338 |
| 48 | Stomatitis (HP:0010280) | 2.40635556 |
| 49 | Granulocytopenia (HP:0001913) | 2.38752703 |
| 50 | Gingivitis (HP:0000230) | 2.38084608 |
| 51 | Urticaria (HP:0001025) | 2.37294687 |
| 52 | Fatigue (HP:0012378) | 2.32457440 |
| 53 | Osteomyelitis (HP:0002754) | 2.31759680 |
| 54 | Slow saccadic eye movements (HP:0000514) | 2.31336652 |
| 55 | Chest pain (HP:0100749) | 2.28518867 |
| 56 | Lymphopenia (HP:0001888) | 2.26530448 |
| 57 | Autoimmune thrombocytopenia (HP:0001973) | 2.26129576 |
| 58 | IgM deficiency (HP:0002850) | 2.25990767 |
| 59 | Pulmonary infiltrates (HP:0002113) | 2.23677817 |
| 60 | Episodic fever (HP:0001954) | 2.21863692 |
| 61 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.21074325 |
| 62 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.17976279 |
| 63 | Hemoptysis (HP:0002105) | 2.15240042 |
| 64 | Acute lymphatic leukemia (HP:0006721) | 2.14906149 |
| 65 | Peritonitis (HP:0002586) | 2.14608982 |
| 66 | Syringomyelia (HP:0003396) | 2.14007768 |
| 67 | Spinal cord lesions (HP:0100561) | 2.14007768 |
| 68 | Pulmonary embolism (HP:0002204) | 2.10238886 |
| 69 | Pustule (HP:0200039) | 2.08026988 |
| 70 | Verrucae (HP:0200043) | 2.03043888 |
| 71 | Papilloma (HP:0012740) | 2.03043888 |
| 72 | Abnormal platelet volume (HP:0011876) | 2.00066421 |
| 73 | IgA deficiency (HP:0002720) | 1.98573477 |
| 74 | Leukocytosis (HP:0001974) | 1.98002838 |
| 75 | Deep philtrum (HP:0002002) | 1.97947216 |
| 76 | Abnormality of the common coagulation pathway (HP:0010990) | 1.97851301 |
| 77 | Gangrene (HP:0100758) | 1.96503496 |
| 78 | Hepatitis (HP:0012115) | 1.96269887 |
| 79 | Dislocated radial head (HP:0003083) | 1.93543294 |
| 80 | Lymphoma (HP:0002665) | 1.93183543 |
| 81 | Anorexia (HP:0002039) | 1.93113406 |
| 82 | Abnormality of B cell number (HP:0010975) | 1.92376942 |
| 83 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.89966672 |
| 84 | Eosinophilia (HP:0001880) | 1.88708020 |
| 85 | Abnormality of the pleura (HP:0002103) | 1.88630215 |
| 86 | Menorrhagia (HP:0000132) | 1.88451347 |
| 87 | Acute myeloid leukemia (HP:0004808) | 1.86507923 |
| 88 | B lymphocytopenia (HP:0010976) | 1.84834171 |
| 89 | Deep venous thrombosis (HP:0002625) | 1.84776424 |
| 90 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.84229360 |
| 91 | Recurrent sinusitis (HP:0011108) | 1.83964672 |
| 92 | Somatic mutation (HP:0001428) | 1.83076325 |
| 93 | Glomerulopathy (HP:0100820) | 1.81742177 |
| 94 | Sepsis (HP:0100806) | 1.80822514 |
| 95 | Abnormality of the endocardium (HP:0004306) | 1.77695439 |
| 96 | Dysmetric saccades (HP:0000641) | 1.76384683 |
| 97 | Recurrent bronchitis (HP:0002837) | 1.75192377 |
| 98 | Thrombophlebitis (HP:0004418) | 1.73906070 |
| 99 | Papilledema (HP:0001085) | 1.73905447 |
| 100 | Basal cell carcinoma (HP:0002671) | 1.73585931 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 4.55852836 |
| 2 | PRPF4B | 3.27373118 |
| 3 | CDK12 | 2.99770640 |
| 4 | MAP4K1 | 2.95604333 |
| 5 | MAP3K14 | 2.91254593 |
| 6 | IRAK4 | 2.69299192 |
| 7 | BLK | 2.47950605 |
| 8 | MAP2K3 | 2.38962262 |
| 9 | TYK2 | 2.08984469 |
| 10 | BMPR2 | 1.99536114 |
| 11 | SIK2 | 1.88897284 |
| 12 | ERN1 | 1.87635886 |
| 13 | BTK | 1.76679992 |
| 14 | IRAK3 | 1.72144762 |
| 15 | MAP3K13 | 1.70251447 |
| 16 | CSK | 1.69899507 |
| 17 | JAK1 | 1.65822930 |
| 18 | BRD4 | 1.64985104 |
| 19 | TRIB3 | 1.62168017 |
| 20 | ZAP70 | 1.62144348 |
| 21 | JAK3 | 1.58165915 |
| 22 | SYK | 1.56541332 |
| 23 | TAOK3 | 1.44788072 |
| 24 | IKBKE | 1.42134745 |
| 25 | IRAK1 | 1.41157221 |
| 26 | FGFR3 | 1.40631003 |
| 27 | HCK | 1.40505939 |
| 28 | KSR2 | 1.40120504 |
| 29 | SIK3 | 1.36820599 |
| 30 | IRAK2 | 1.33807760 |
| 31 | FGFR4 | 1.29305115 |
| 32 | MAP3K10 | 1.28033154 |
| 33 | TEC | 1.25175119 |
| 34 | GRK6 | 1.22234673 |
| 35 | SMG1 | 1.20807271 |
| 36 | FES | 1.19766586 |
| 37 | FGR | 1.18507475 |
| 38 | TBK1 | 1.14528449 |
| 39 | IKBKB | 1.14375512 |
| 40 | JAK2 | 1.13238826 |
| 41 | WNK1 | 1.10915689 |
| 42 | MATK | 1.09303192 |
| 43 | YES1 | 1.07455785 |
| 44 | NEK9 | 1.06864584 |
| 45 | ITK | 1.03884329 |
| 46 | KIT | 1.02946829 |
| 47 | LYN | 0.99080130 |
| 48 | ICK | 0.98640451 |
| 49 | CDC42BPA | 0.97158280 |
| 50 | TNK2 | 0.96638938 |
| 51 | TXK | 0.94567286 |
| 52 | MAP3K1 | 0.93178738 |
| 53 | CDK4 | 0.92377220 |
| 54 | AKT3 | 0.91209012 |
| 55 | EPHB1 | 0.91173305 |
| 56 | MARK3 | 0.87435449 |
| 57 | LCK | 0.86344022 |
| 58 | MAP3K7 | 0.86064977 |
| 59 | SIK1 | 0.85591073 |
| 60 | CDK6 | 0.84459991 |
| 61 | MARK2 | 0.83326898 |
| 62 | STK10 | 0.82977662 |
| 63 | MAP3K2 | 0.82275592 |
| 64 | PIK3CG | 0.81312091 |
| 65 | MAPK11 | 0.79913431 |
| 66 | CHUK | 0.76514516 |
| 67 | EEF2K | 0.75516345 |
| 68 | CLK1 | 0.75137812 |
| 69 | TAOK1 | 0.74779437 |
| 70 | TAOK2 | 0.73642508 |
| 71 | MAP3K3 | 0.73164714 |
| 72 | PIM1 | 0.70224684 |
| 73 | CSF1R | 0.67659182 |
| 74 | MELK | 0.65374390 |
| 75 | MAP3K6 | 0.64409172 |
| 76 | CAMK1D | 0.64175651 |
| 77 | RAF1 | 0.61697784 |
| 78 | SGK3 | 0.61513412 |
| 79 | MAPK12 | 0.60037416 |
| 80 | TRPM7 | 0.59624299 |
| 81 | RET | 0.57606085 |
| 82 | PDK1 | 0.56812190 |
| 83 | MAP3K5 | 0.56211483 |
| 84 | PKN2 | 0.55252723 |
| 85 | MTOR | 0.53106972 |
| 86 | MKNK1 | 0.52681845 |
| 87 | SGK2 | 0.50152296 |
| 88 | NLK | 0.48805789 |
| 89 | ALK | 0.48784954 |
| 90 | MAPK7 | 0.48058336 |
| 91 | MAP3K8 | 0.47906175 |
| 92 | PDPK1 | 0.47846716 |
| 93 | PRKCQ | 0.47328696 |
| 94 | PTK6 | 0.44617439 |
| 95 | KSR1 | 0.42483216 |
| 96 | PDGFRB | 0.39606080 |
| 97 | CAMK1G | 0.39016353 |
| 98 | PRKD2 | 0.37671277 |
| 99 | PRKAA2 | 0.35427039 |
| 100 | RPS6KB2 | 0.33934827 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.85201560 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 2.58869222 |
| 3 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.41403495 |
| 4 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.19742556 |
| 5 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 2.12506634 |
| 6 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.99879268 |
| 7 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.98275394 |
| 8 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.95295257 |
| 9 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.85334420 |
| 10 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.83804448 |
| 11 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.82449787 |
| 12 | Measles_Homo sapiens_hsa05162 | 1.81313897 |
| 13 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.76869695 |
| 14 | Tuberculosis_Homo sapiens_hsa05152 | 1.75104089 |
| 15 | Influenza A_Homo sapiens_hsa05164 | 1.71903164 |
| 16 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.71183007 |
| 17 | Hepatitis B_Homo sapiens_hsa05161 | 1.69706541 |
| 18 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.69061222 |
| 19 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.60882004 |
| 20 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.60349952 |
| 21 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.55597275 |
| 22 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.52334983 |
| 23 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.51361273 |
| 24 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.49356797 |
| 25 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.49196404 |
| 26 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.48283089 |
| 27 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.46406398 |
| 28 | Allograft rejection_Homo sapiens_hsa05330 | 1.42220090 |
| 29 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.38155831 |
| 30 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.35674921 |
| 31 | Other glycan degradation_Homo sapiens_hsa00511 | 1.32543663 |
| 32 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.27364294 |
| 33 | Apoptosis_Homo sapiens_hsa04210 | 1.25659567 |
| 34 | Hepatitis C_Homo sapiens_hsa05160 | 1.25263717 |
| 35 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.18588553 |
| 36 | Legionellosis_Homo sapiens_hsa05134 | 1.18134316 |
| 37 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.17491500 |
| 38 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.17270922 |
| 39 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.16308834 |
| 40 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.15945461 |
| 41 | Malaria_Homo sapiens_hsa05144 | 1.15610106 |
| 42 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.14019971 |
| 43 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.12487684 |
| 44 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.09315244 |
| 45 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.06800889 |
| 46 | Platelet activation_Homo sapiens_hsa04611 | 1.05308185 |
| 47 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.01176711 |
| 48 | Endometrial cancer_Homo sapiens_hsa05213 | 0.99126866 |
| 49 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.97893415 |
| 50 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.97441777 |
| 51 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.97219066 |
| 52 | Prostate cancer_Homo sapiens_hsa05215 | 0.96688806 |
| 53 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.96506164 |
| 54 | Viral myocarditis_Homo sapiens_hsa05416 | 0.96314617 |
| 55 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.95248187 |
| 56 | Colorectal cancer_Homo sapiens_hsa05210 | 0.95148861 |
| 57 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.94733433 |
| 58 | Asthma_Homo sapiens_hsa05310 | 0.94281532 |
| 59 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.92988110 |
| 60 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.91232233 |
| 61 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.91145322 |
| 62 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.89054301 |
| 63 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.89008226 |
| 64 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.85771044 |
| 65 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.84097556 |
| 66 | Bladder cancer_Homo sapiens_hsa05219 | 0.83432060 |
| 67 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.81877359 |
| 68 | Insulin resistance_Homo sapiens_hsa04931 | 0.78146962 |
| 69 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.77914692 |
| 70 | Glioma_Homo sapiens_hsa05214 | 0.77818013 |
| 71 | Shigellosis_Homo sapiens_hsa05131 | 0.76533129 |
| 72 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.76371429 |
| 73 | HTLV-I infection_Homo sapiens_hsa05166 | 0.75706769 |
| 74 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.75604023 |
| 75 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.75030395 |
| 76 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.73479644 |
| 77 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.72758064 |
| 78 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.71678053 |
| 79 | Pertussis_Homo sapiens_hsa05133 | 0.70645658 |
| 80 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.70203736 |
| 81 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.69306500 |
| 82 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.68802860 |
| 83 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.65163013 |
| 84 | Amoebiasis_Homo sapiens_hsa05146 | 0.62046401 |
| 85 | Thyroid cancer_Homo sapiens_hsa05216 | 0.59924778 |
| 86 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.58124783 |
| 87 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.53843904 |
| 88 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.51921723 |
| 89 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.51306657 |
| 90 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.51210303 |
| 91 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.50850067 |
| 92 | Phagosome_Homo sapiens_hsa04145 | 0.50582009 |
| 93 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.49202677 |
| 94 | Lysine degradation_Homo sapiens_hsa00310 | 0.47833363 |
| 95 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.47520200 |
| 96 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.46699091 |
| 97 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.46507968 |
| 98 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.45593922 |
| 99 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.44266111 |
| 100 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.44097007 |

